BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 26337396)

  • 61. Supragastric belching in patients with reflux symptoms.
    Hemmink GJ; Bredenoord AJ; Weusten BL; Timmer R; Smout AJ
    Am J Gastroenterol; 2009 Aug; 104(8):1992-7. PubMed ID: 19455107
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Prevalence, characteristics, and treatment outcomes of reflux hypersensitivity detected on pH-impedance monitoring.
    Patel A; Sayuk GS; Gyawali CP
    Neurogastroenterol Motil; 2016 Sep; 28(9):1382-90. PubMed ID: 27061427
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of anti-reflux surgery on weakly acidic reflux and belching.
    Broeders JA; Bredenoord AJ; Hazebroek EJ; Broeders IA; Gooszen HG; Smout AJ
    Gut; 2011 Apr; 60(4):435-41. PubMed ID: 21193452
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus.
    Ribolsi M; Frazzoni M; Marabotto E; De Carlo G; Ziola S; Maniero D; Balestrieri P; Cicala M; Savarino E
    Aliment Pharmacol Ther; 2021 Aug; 54(4):412-418. PubMed ID: 34181753
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy of endoluminal gastroplication in Japanese patients with proton pump inhibitor-resistant, non-erosive esophagitis.
    Tokudome K; Funaki Y; Sasaki M; Izawa S; Tamura Y; Iida A; Ogasawara N; Konagaya T; Tokura Y; Kasugai K
    World J Gastroenterol; 2012 Nov; 18(41):5940-7. PubMed ID: 23139611
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Refractory GERD: increased body mass index is associated with persisting acid exposure but not hypersensitive esophagus or functional heartburn.
    Viazis N; Karamanolis GP; Anastasiou J; Keyoglou A; Vlachogiannakos J; Ladas SD; Karamanolis DG
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1450-5. PubMed ID: 24047861
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors.
    Sifrim D; Zerbib F
    Gut; 2012 Sep; 61(9):1340-54. PubMed ID: 22684483
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Gastro-esophageal reflux and antisecretory drugs use among patients with chronic autoimmune atrophic gastritis: a study with pH-impedance monitoring.
    Tenca A; Massironi S; Pugliese D; Consonni D; Mauro A; Cavalcoli F; Franchina M; Spampatti M; Conte D; Penagini R
    Neurogastroenterol Motil; 2016 Feb; 28(2):274-80. PubMed ID: 26568317
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Increased prandial air swallowing and postprandial gas-liquid reflux among patients refractory to proton pump inhibitor therapy.
    Bravi I; Woodland P; Gill RS; Al-Zinaty M; Bredenoord AJ; Sifrim D
    Clin Gastroenterol Hepatol; 2013 Jul; 11(7):784-9. PubMed ID: 23376324
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Correlation between hypersensitivity induced by esophageal acid infusion and the baseline impedance level in patients with suspected gastroesophageal reflux.
    Seo AY; Shin CM; Kim N; Yoon H; Park YS; Lee DH
    J Gastroenterol; 2015 Jul; 50(7):735-43. PubMed ID: 25479939
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Role of esophageal manometry and 24-h pH testing in patients with refractory reflux symptoms.
    Jain M; Agrawal V
    Indian J Gastroenterol; 2020 Apr; 39(2):165-170. PubMed ID: 32388711
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Role of Esophageal Motility, Acid Reflux, and of Acid Suppression in Nonobstructive Dysphagia.
    Ribolsi M; Biasutto D; Giordano A; Balestrieri P; Cicala M
    J Clin Gastroenterol; 2018 Aug; 52(7):607-613. PubMed ID: 28787356
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy.
    Pritchett JM; Aslam M; Slaughter JC; Ness RM; Garrett CG; Vaezi MF
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):743-8. PubMed ID: 19281866
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease.
    Slaughter JC; Goutte M; Rymer JA; Oranu AC; Schneider JA; Garrett CG; Hagaman D; Vaezi MF
    Clin Gastroenterol Hepatol; 2011 Oct; 9(10):868-74. PubMed ID: 21782769
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of proton pump inhibitor (PPI) treatment in obstructive sleep apnea syndrome: an esophageal impedance-pHmetry study.
    Ermis F; Akyuz F; Arici S; Uyanikoglu A; Yakar F; Pinarbasi B; Demir K; Ozdil S; Besisik F; Kaymakoglu S; Boztas G; Cuhadaroglu C; Mungan Z
    Hepatogastroenterology; 2011; 58(110-111):1566-73. PubMed ID: 21940322
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Role of Reflux in the Pathogenesis of Eosinophilic Esophagitis: Comprehensive Appraisal With Off- and On PPI Impedance-pH Monitoring.
    Frazzoni M; Penagini R; Frazzoni L; de Bortoli N; Mauro A; Tolone S; Bertani H; Marsico M; Marocchi M; Marchi S; Conigliaro R; Savarino E
    Am J Gastroenterol; 2019 Oct; 114(10):1606-1613. PubMed ID: 31449157
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Adding Acotiamide to Gastric Acid Inhibitors Is Effective for Treating Refractory Symptoms in Patients with Non-erosive Reflux Disease.
    Yamashita H; Okada A; Naora K; Hongoh M; Kinoshita Y
    Dig Dis Sci; 2019 Mar; 64(3):823-831. PubMed ID: 30465175
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Esophageal chemical clearance is impaired in gastro-esophageal reflux disease--a 24-h impedance-pH monitoring assessment.
    Frazzoni M; Manta R; Mirante VG; Conigliaro R; Frazzoni L; Melotti G
    Neurogastroenterol Motil; 2013 May; 25(5):399-406, e295. PubMed ID: 23360178
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Identification of Different Phenotypes of Esophageal Reflux Hypersensitivity and Implications for Treatment.
    Sawada A; Guzman M; Nikaki K; Sonmez S; Yazaki E; Aziz Q; Woodland P; Rogers B; Gyawali CP; Sifrim D
    Clin Gastroenterol Hepatol; 2021 Apr; 19(4):690-698.e2. PubMed ID: 32272249
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Characteristics of symptomatic reflux episodes in Japanese proton pump inhibitor-refractory non-erosive reflux disease patients.
    Nakagawa K; Koike T; Iijima K; Saito M; Kikuchi H; Hatta W; Ara N; Uno K; Asano N; Shimosegawa T
    World J Gastroenterol; 2015 Dec; 21(47):13352-9. PubMed ID: 26715820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.